acetylshikonin has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, H; Cheng, J; Huang, X; Jiang, X; Tang, Y; Wang, L; Wang, X; Wang, Y; Xie, M; Yang, L; Zhang, L; Zhao, C; Zhao, Z | 1 |
1 other study(ies) available for acetylshikonin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Acetylshikonin exerts anti-tumor effects on non-small cell lung cancer through dual inhibition of STAT3 and EGFR.
Topics: Animals; Anthraquinones; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Humans; Lung Neoplasms; Mice; Mice, Nude; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2022 |